Sign in
4

Changes in Ownership

Beam Therapeutics Inc. Filed Acc 0001193125-26-144086

CEO sold 30,078 shares at $24.58 ($739,317)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Evans John M. CEO 2026-04-01 Sale 10b5-1 −30,078 $24.58 $739,317 1,047,205 D: show line 1 in the form
Open-market sales · 30,078 sh · avg $24.58 · $739,317
Loading xslF345X06/ownership.xml…